Neonatal General 12: Prenatal Exposures

Neonatal General 12: Prenatal Exposures

426 - Evaluating Effects of Prenatal THC and Tobacco Exposure on Neonatal Lung Mechanics

435 - Placental size and neonatal opioid withdrawal syndrome

436 - Correlation between maternal dose of medication for opioid use disorder and drug levels in maternal urine and infant cord toxicology analysis

437 - The impact of the implementation of Eat, Sleep, Console for the management of infants with Neonatal Opioid Withdrawal Syndrome on the morphine dose and length of stay

438 - Frequency of Nasogastric Feeding Among Newborns with Opioid Withdrawal Syndrome Managed with the Modified Finnigan (MF) or Eat, Sleep, Console (ESC) Protocols

439 - Comparison of Umbilical Cord and Meconium Toxicology Testing

440 - Comparing Developmental and Growth Trajectories in Infants with and without Pharmacotherapy for Neonatal Opioid Withdrawal Syndrome: A Retrospective Cohort Study

441 - Ethanol causes dose dependent alterations of BK distribution in Lipid Rafts of the Nucleus tractus solitarius of rat pups

442 - In utero xylazine exposure is associated with feeding difficulties in infants with Neonatal Opioid Withdrawal Syndrome

443 - Postnatal Head Ultrasound Findings in Preterm Infants Exposed Prenatally to Marijuana

444 - QTc Comparison Between Neonates with Neonatal Opioid Withdrawal Syndrome and Healthy Non-Opioid Exposed Neonates

427 - Developing a Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Further Characterize Impact on Neurodevelopmental Outcomes

445 - Postnatal Morbidity in Neonates with Prenatal Exposure to Xylazine: A Case Series

428 - Bowen Therapy for Nonpharmacologic Care of Patients with Neonatal Abstinence Syndrome

429 - Neonatal abstinence syndrome, complications beyond withdrawal symptoms

430 - Change in maternal e-cigarette use during pregnancy and preterm birth

431 - Mothers with Concurrent Cocaine and Opioid Use and Neonatal Outcomes

432 - Maternal dosage and urine/cord drug levels of medication for opioid use disorder as predictors of pharmacologic treatment for neonatal opioid withdrawal syndrome

433 - Concordance of test results between maternal drug screen and urine versus cord tissue drug screens in newborns

434 - Nasogastric and orogastric tube feeding among infants with intrauterine opioid exposure